首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma:Recent developments and insights

Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma:Recent developments and insights

Cheng Xie Jian-Ji Ke Fei-Qi Liu

Hepatobiliary & Pancreatic Diseases International2026，Vol.25Issue(4)：P.362-374,13.

Hepatobiliary & Pancreatic Diseases International2026，Vol.25Issue(4)：P.362-374,13.DOI:10.1016/j.hbpd.2025.12.008

Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma:Recent developments and insights

Cheng Xie ¹Jian-Ji Ke ¹Fei-Qi Liu²

作者信息

1. Department of Hepatobiliary and Pancreatic Surgery,General Surgery Center,The First Hospital of Jilin University,Changchun 130000,China
2. Department of Critical Care Medicine,The First Hospital of Jilin University,Changchun 130000,China
折叠

摘要

关键词

Pancreatic ductal adenocarcinoma/Targeted therapy/Immunotherapy/Clinical trials

分类

医药卫生

引用本文复制引用

Cheng Xie,Jian-Ji Ke,Fei-Qi Liu..Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma:Recent developments and insights[J].Hepatobiliary & Pancreatic Diseases International,2026,25(4):P.362-374,13.

基金项目

supported by a grant from the Young Scientists Fund of The First Hospital of Jilin University(No.JDYY14202313). （No.JDYY14202313）

Hepatobiliary & Pancreatic Diseases International

ISSN：1499-3872

访问量0

下载量0

段落导航